We then performed a cytotoxicity LDH assay, an assessment of soluble and insoluble tau, a triplication analysis using multiple AD cases, and an in vitro AD seed-dependent RT-QuIC assay. The gene discussed is MAPT; the disease is Alzheimer disease.